I/O

Immuno-oncology, also known as cancer immunotherapy, is a therapeutic approach that harnesses the power of a patient’s own immune system to recognize and eliminate cancer cells.

This field sits at the interface of immunology and oncology, leveraging scientific knowledge from both disciplines to effectively develop novel strategies for the treatment of devastating cancers.

Our team is dedicated to supporting innovations in immuno-oncology through a range of service offerings, and we have extensive experience working with relevant cell models in culture.

We can provide targeted analysis of immuno-oncology biomarkers (QuantScout™) to gain a better understanding of the interplay between the immune system and tumors, assess therapeutic efficacy, and identify patient subgroups. We can also perform comprehensive profiling of proteomes (ProteomeScout™) and cell surface proteomes (SurfaceScout™) to identify promising targets or markers for patient stratification. In addition, all of our profiling technologies can be leveraged for the proteome-wide analysis of tumor samples, enhancing understanding of disease biology and treatment efficacy.